Ischemic stroke is a vascular central nervous system (CNS) disease that leads a disability
and death. Thrombolysis and neuroprotection are the primary treatment strategies of …

Cerebral ischemic stroke remains one of the most serious neurological disorders that pose
threats to human health, causing a large amount of long-term disability or even death …

Apoptotic vesicles (ApoVs) hold great promise for inflammatory regulation and tissue repair.
However, little effort has been dedicated to developing ApoV-based drug delivery platforms …

Ischemic stroke is one of the major causes of death and disability worldwide, and an
effective and timely treatment of ischemic stroke has been a challenge because of the …

Due to the high recurrence rate and mortality of venous thrombosis, there is an urgent need
for research on antithrombotic strategies. Because of the short half‐life, poor targeting …

Currently, the limited efficacy of antithrombotic treatments is attributed to the inadequacy of
pure drugs and the low ability of drugs to target the thrombus site. More importantly, timely …

Mesenchymal stem cells (MSCs) exhibited remarkable therapeutic potential in ischemic
stroke due to their exceptional immunomodulatory ability and paracrine effect; they have …

Acute myocardial infarction (AMI) is usually caused by coronary thrombosis. However, the
short half-life, lack of targetability and inevitable ischemia/reperfusion injury secondary to …

Mitochondrial dysfunction and subsequent accumulation of reactive oxygen species (ROS)
are key contributors to the pathology of ischemic cerebrovascular disease. Therefore …

Traditional thrombolytic therapeutics for vascular blockage are affected by their limited
penetration into thrombi, associated off‐target side effects, and low bioavailability, leading to …